Amarin Hits Back Over SCOTUS Skinny-Label Review

Originator Maintains Hikma Circumvented Law To Infringe Vascepa Patents

 
• By Dave Wallace
  
Amarin is pushing back against a potential Supreme Court reversal (Shutterstock)

More from Legal & IP

More from Generics Bulletin